Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
← catalyst calendarNCT06483945 · readout in 590 d
Sponsored by DexCom, Inc. (industry) · DXCM — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
5,000estimated
Sites
2
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-02-28 | actual | When the study began enrolling |
| Primary completion | 2028-03-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-06-30 | estimated | The whole study's end, after follow-up |
| First posted | 2024-07-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-07-03 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Diabetes
Intervention
- Device: Dexcom CGM G6/G6 Pro/G7
Primary outcome
what the primary-completion date above is the date OFPatient Reported Outcomes (PROs)
measured 4 years
Permalink · DXCM's whole pipeline · Catalyst calendar · Every registered study · What changed